Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Neuronal acetylcholine receptor; alpha4/beta2 | Starlite/ChEMBL | References |
Rattus norvegicus | Neuronal acetylcholine receptor protein alpha-7 subunit | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | hexokinase | 0.0163 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0944 | 0.0944 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.3035 | 0.3035 |
Echinococcus multilocularis | hexokinase type 2 | 0.0163 | 1 | 1 |
Trypanosoma cruzi | hexokinase, putative | 0.0163 | 1 | 1 |
Onchocerca volvulus | 0.0163 | 1 | 1 | |
Onchocerca volvulus | 0.0123 | 0.3035 | 0.0205 | |
Echinococcus granulosus | hexokinase type 2 | 0.0163 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0163 | 1 | 1 |
Echinococcus granulosus | hexokinase | 0.0163 | 1 | 1 |
Trypanosoma cruzi | hexokinase, putative | 0.0163 | 1 | 1 |
Leishmania major | hexokinase, putative | 0.0163 | 1 | 1 |
Plasmodium vivax | hexokinase, putative | 0.0163 | 1 | 1 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0122 | 0.2889 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0122 | 0.2889 | 0.5 |
Schistosoma mansoni | hexokinase | 0.0163 | 1 | 1 |
Loa Loa (eye worm) | hexokinase type II | 0.0163 | 1 | 1 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0122 | 0.2889 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0122 | 0.2889 | 0.5 |
Echinococcus granulosus | hexokinase | 0.0163 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0163 | 1 | 1 |
Brugia malayi | Hexokinase family protein | 0.0163 | 1 | 1 |
Entamoeba histolytica | hexokinase 2 | 0.0163 | 1 | 1 |
Schistosoma mansoni | nAChR subunit (ShAR1-alpha-like) | 0.0123 | 0.3035 | 0.0205 |
Entamoeba histolytica | hexokinase 1 | 0.0163 | 1 | 1 |
Echinococcus granulosus | hexokinase | 0.0163 | 1 | 1 |
Onchocerca volvulus | 0.0123 | 0.3035 | 0.0205 | |
Onchocerca volvulus | 0.0163 | 1 | 1 | |
Onchocerca volvulus | 0.0163 | 1 | 1 | |
Echinococcus multilocularis | hexokinase | 0.0163 | 1 | 1 |
Brugia malayi | Cation transporter family protein | 0.0123 | 0.3035 | 0.0205 |
Echinococcus multilocularis | hexokinase | 0.0163 | 1 | 1 |
Echinococcus multilocularis | hexokinase | 0.0163 | 1 | 1 |
Onchocerca volvulus | 0.0123 | 0.3035 | 0.0205 | |
Treponema pallidum | hexokinase (hxk) | 0.0163 | 1 | 1 |
Leishmania major | hexokinase, putative | 0.0163 | 1 | 1 |
Toxoplasma gondii | hexokinase | 0.0163 | 1 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0122 | 0.2889 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.3035 | 0.3035 |
Trypanosoma brucei | hexokinase | 0.0163 | 1 | 1 |
Schistosoma mansoni | nAChR subunit (ShAR1-beta-like) | 0.0123 | 0.3035 | 0.0205 |
Trypanosoma brucei | hexokinase, putative | 0.0163 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.2889 | 0.2889 |
Plasmodium falciparum | hexokinase | 0.0163 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 197.3 nM | Displacement of [3H]epibatidine from alpha4beta2 nAChR in Sprague-Dawley rat forebrain P2 fraction after 90 mins by liquid scintillation counting analysis | ChEMBL. | 24156938 |
Ki (binding) | > 10000 nM | Displacement of [3H]methyllycaconitine from alpha7 nAChR in Sprague-Dawley rat forebrain P2 fraction after 90 mins by liquid scintillation counting analysis | ChEMBL. | 24156938 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.